Guardant Health Inc (GH)
28.68
-0.28
(-0.97%)
USD |
NASDAQ |
Nov 19, 09:33
Guardant Health Revenue (TTM): 692.26M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 692.26M |
| June 30, 2024 | 643.81M |
| March 31, 2024 | 603.72M |
| December 31, 2023 | 563.95M |
| September 30, 2023 | 535.78M |
| June 30, 2023 | 510.16M |
| March 31, 2023 | 482.15M |
| December 31, 2022 | 449.54M |
| September 30, 2022 | 430.76M |
| June 30, 2022 | 408.13M |
| March 31, 2022 | 391.09M |
| December 31, 2021 | 373.65M |
| September 30, 2021 | 343.86M |
| Date | Value |
|---|---|
| June 30, 2021 | 323.65M |
| March 31, 2021 | 297.88M |
| December 31, 2020 | 286.73M |
| September 30, 2020 | 271.31M |
| June 30, 2020 | 257.59M |
| March 31, 2020 | 245.23M |
| December 31, 2019 | 214.38M |
| September 30, 2019 | 184.35M |
| June 30, 2019 | 145.20M |
| March 31, 2019 | 110.60M |
| December 31, 2018 | 90.64M |
| September 30, 2018 | 77.77M |
| June 30, 2018 | 67.21M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
214.38M
Minimum
Dec 2019
692.26M
Maximum
Sep 2024
416.28M
Average
399.61M
Median
Revenue (TTM) Benchmarks
| Exact Sciences Corp | 2.692B |
| Delcath Systems Inc | 22.64M |
| Star Equity Holdings Inc | 47.15M |
| CytoSorbents Corp | 33.79M |
| Progyny Inc | 1.139B |